SCIENTIFIC BACKGROUND

GLA

SCIENTIFIC BACKGROUND

Fabry disease (also known as alpha galactosidase) is a lysosomal storage disease and a congenital, X-linked disorder of the glycosphingolipid catabolism caused by a reduced or absent activity of the lysosomal enzyme alpha-galactosidase A (GLA). Pathogenic variants in the GLA gene are causative. The enzyme deficiency leads to a progressive systemic accumulation of glycosphingolipids in various tissues and organs. To avoid serious complications, an early diagnosis is crucial to initiate therapy. Symptoms of Fabry disease include angiokeratomas, pain attacks, and organ dysfunction, which may lead to stroke and myocardial infarction; dialysis may be required. Time of initial manifestation and course of the disease are highly variable, with symptoms commonly occurring in childhood.

 

The prevalence of classic Fabry disease in men is estimated at approximately 1:40,000. Unlike the majority of other X-linked disorders, heterozygous females are rarely asymptomatic and may develop symptoms requiring treatment or even present with the complete disease. One hypothesis for phenotypic variability in heterozygous women is skewed X inactivation.

 

Enzyme substitution therapy has been available in Europe since 2001. Since 2016, patients over the age of 16 with confirmed Fabry disease have the alternative option of oral chaperone therapy with the active ingredient migalastat. Since the therapy is only effective in the presence of certain variants in the GLA gene, the patient's GLA genotype must be known. A list of the individual variants can be found in the summary of product characteristics for Galafold.

 

References

Mehta and Hughes, 2002 Aug 5 [Updated 2017 Jan 5]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. / Schäfer et al. 2005, Hum Mutat. 25:412 / Eng et al. 1993, Am J Hum Gen 53:1186 / Fachinformation Galafold

GENES

GLA

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more

Aneuploidies, such as translocations, whole or segmental chromosomal duplications, and deletions, are examples of chromosomal abnormalities that are ...

Read more

Here you can read the winning essays from the first, annual DNA essay competition on the subject of "How unfolding the DNA code can help with precisi...

Read more

Introduction Our voices are as unique as our fingerprints! Although there are people whose voices might sound alike, there are no two voices exact...

Read more

Not everyone likes winter. For people who do not enjoy the cold weather, or having to put on a thick coat to go outside, a winter can be a source of ...

Read more